Clinical Trial Update: Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses [NA]

View source ↗

Summary

A clinical trial evaluating AcrySof IQ Vivity Extended Vision intraocular lenses has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphakia
• Presbyopia
• Residual Refractive Cylinder

Drugs mentioned

• AcrySof IQ Vivity Extended Vision Intraocular Lens (AcrySof IQ Vivity Extended Vision IOL)

Snippet

Sponsor: Alcon Research | Conditions: Aphakia, Presbyopia | NA | Status: WITHDRAWN